Fennec Pharmaceuticals (FENC) Earnings Date, Estimates & Call Transcripts $4.48 +0.25 (+5.91%) (As of 11/13/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Fennec Pharmaceuticals Latest Earnings SummaryUpcoming Q3 Earnings DateMar. 20EstimatedActual EPS (Aug. 13) -$0.20 Missed By -$0.26 Consensus EPS (Aug. 13) $0.06 Fennec Pharmaceuticals issued Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.20, which missed analysts' consensus estimates of $0.06 by $0.26. Quarterly revenue was reported to be $7.26 million, below the consensus estimate of $13.67 million. With a trailing EPS of -$0.10, Fennec Pharmaceuticals' earnings are expected to decrease -37.50% next year, from $0.08 to $0.05 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseFENC Upcoming EarningsFennec Pharmaceuticals' next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules. Get Fennec Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataFENC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FENC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Fennec Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.05-$0.02-$0.04Q2 20243-$0.17$0.42$0.06Q3 20243-$0.16$0.24-$0.01Q4 20243-$0.13$0.28$0.06FY 202411-$0.51$0.92$0.07Q1 20253-$0.02$0.09$0.04Q2 20253$0.00$0.55$0.25Q3 20253$0.04$1.27$0.52Q4 20253$0.05$2.56$0.98FY 202512$0.07$4.47$1.79 Fennec Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/20/2025(Estimated)------- 8/13/2024Q2 2024$0.06-$0.20 -$0.26-$0.20$13.67M$7.26M 5/14/2024Q1 2024$0.49$0.41 -$0.08$0.41$10.46M$25.38M 3/21/2024Q4 2023$0.02-$0.10 -$0.12-$0.10$9.47M$9.74M 11/6/2023Q3 2023-$0.11-$0.07+$0.04-$0.07$5.22M$6.52M 8/3/2023Q2 2023-$0.18-$0.21 -$0.03-$0.21$4.01M$3.33M 5/11/2023Q1 2023-$0.21-$0.23 -$0.02-$0.23$1.88M$1.68M Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022-$0.24-$0.26 -$0.02-$0.26$1.97M$1.54M Fennec Pharmaceuticals Earnings - Frequently Asked Questions When is Fennec Pharmaceuticals's earnings date? Fennec Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on FENC's earnings history. Did Fennec Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Fennec Pharmaceuticals (NASDAQ:FENC) missed the analysts' consensus estimate of $0.06 by $0.26 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. FENC's actual earnings. How can I listen to Fennec Pharmaceuticals's earnings conference call? The conference call for Fennec Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Fennec Pharmaceuticals's conference call transcript? The conference call transcript for Fennec Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded annual revenue of $48.89 million. How much profit does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded net income of -$16.05 million. FENC has generated -$0.10 earnings per share over the last four quarters. What is Fennec Pharmaceuticals's EPS forecast for next year? Fennec Pharmaceuticals's earnings are expected to decrease from $0.08 per share to $0.05 per share in the next year, which is a -37.50% change. ` More Earnings Resources from MarketBeat Related Companies C4 Therapeutics Earnings Date Valneva Earnings Date 4D Molecular Therapeutics Earnings Date MeiraGTx Earnings Date Voyager Therapeutics Earnings Date Jasper Therapeutics Earnings Date Sutro Biopharma Earnings Date enGene Earnings Date iTeos Therapeutics Earnings Date Artiva Biotherapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. This page (NASDAQ:FENC) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.